GAO Finds HHS Illegally Withheld Over $78 Million in Grant Funds

The Government Accountability Office (GAO) has issued a significant report revealing that the Department of Health and Human Services (HHS) improperly withheld more than $78 million in grant funds meant for the Agency for Healthcare Research and Quality (AHRQ) in fiscal year 2025. This finding is particularly troubling as it underscores the need for strict adherence to the Impoundment Control Act of 1974, which mandates that funds appropriated by Congress must be utilized as directed unless explicitly communicated otherwise to Congress. The GAO's analysis concluded that AHRQ had the authority to allocate its appropriation amongst authorized uses but could not legally allow those funds to remain unobligated.

According to GAO, the lump-sum appropriation granted to AHRQ came with the expectation that it would be actively managed to serve its intended purpose. However, with the agency only having disbursed less than 60% of its allocated funds for FY2025, it stands that more than $78 million remains unawarded. This lack of action raises major concerns regarding fiscal prudence and compliance within HHS, particularly in the wake of staffing cuts and funding controversies clouding AHRQ's operational capabilities.

This report comes amidst ongoing scrutiny of HHS's funding practices, driven in part by litigation from health advocacy groups who claim that staffing reductions impeded the agency's ability to issue necessary grants. The GAO's findings could have far-reaching implications not only for HHS and AHRQ but also for grant applicants, recipients, and contractors involved in federal research initiatives.

Particularly noteworthy is the GAO's ongoing investigation that also cites issues with over $1 billion related to EPA Community Change Grants, alongside significant terminations of HHS research grants. These findings can introduce a climate of uncertainty for grantees concerned about funding stability and long-term project viability. It’s critical for organizations engaged with these agencies to closely monitor developments and adapt their funding strategies accordingly.

Furthermore, the White House has indicated plans to recoup $28 million from AHRQ’s $345 million budget for FY2026, labeling a portion of its research as “wasteful or duplicative.” Comments from lawmakers reflect a bipartisan concern regarding executive overreach in spending practices. Lawmakers like Sen. Patty Murray and Rep. Diana DeGette have emphasized that the unauthorized withholding of funds violates Congressional oversight.

Hence, stakeholders are strongly advised to navigate these findings with caution. Current and prospective grantees should utilize agency communications and GAO decisions to comprehensively assess the possible repercussions for funding applications. Additionally, the implications of these events lead to a heightened focus on regulatory compliance and the associated responsibilities of contractors. The GAO report does not impose any new bidding or reporting obligations but highlights significant compliance issues that organizations must consider as they move forward in the increasingly complex landscape of federal grant procurement.

As context shifts and legal challenges regarding these funds evolve, organizations supporting AHRQ research must remain vigilant, particularly as they plan program delivery and funding assumptions based on the dynamics unveiled in these findings. Organizations involved in federal research should enhance their understanding of the funding environment, aligning their strategies with the latest data and legal precedents to better prepare for potential disruptions stemming from government actions.

• The GAO found HHS violated the Impoundment Control Act with over $78 million in unawarded funds.
• A proposed FY2026 rescission seeks to withdraw $28 million of AHRQ's funding.
• Approximately 40% of AHRQ’s fiscal year funds remained unobligated at the reporting time.
• Grant recipients are advised to monitor developments for HHS and AHRQ to mitigate funding uncertainties.
• The ongoing lawsuit continues to shed light on AHRQ's internal challenges, emphasizing compliance failures.
• Stakeholders are reminded no new contractor certification or reporting requirements were enforced by the GAO findings.